Time-dependent effects of imidapril administration in patients with morning hypertension measured as home blood pressure

Clinical and Experimental Hypertension

Volumn 30, Issue 3-4, 2008, Pages 243-254

  Shibasaki, Takako ^a   Obara, Taku ^a   Ohkubo, Takayoshi ^a,b   Hara, Azusa ^a   Metoki, Hirohito ^a   Inoue, Ryusuke ^a   Asayama, Kei ^a   Kikuya, Masahiro ^a   Hashimoto, Junichiro ^a   Totsune, Kazuhito ^a   Imai, Yutaka ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

E M ratio; Home blood pressure; Imidapril; M E ratio; Morning hypertension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIURETIC AGENT; IMIDAPRIL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; TREATMENT RESPONSE;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CIRCADIAN RHYTHM; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART RATE; HUMANS; HYPERTENSION; IMIDAZOLIDINES; MALE; MIDDLE AGED; SELF CARE; TIME FACTORS;

EID: 42349108686     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960802069806     Document Type: Article

References (33)

1. Rocco MB, Barry J, Campbell S, Nabel E, Cook EF, Goldman L, Selwyn AP. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation. 1987;75:395-400.
2. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: The Ohasama study. Hypertension. 2006;47:149-154.
3. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation 2003;107:1401-1406.
4. Strawn WB, Ferrario CM. Mechanisms linking angiotensin II and atherogenesis. Curr Opin Lipidol. 2002;13:505-512.
5. White WB. Cardiovascular risk and the therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press Monit. 2001;6:63-72.
6. Hashimoto J, Imai Y, Minami N, Munakata M, Sakuma H, Sasaki S, Yoshinaga K, Abe K. A high-salt diet alters circadian rhythm in Dahl rats. Tohoku J Exp Med. 1994;173:345-354.
7. Chonan K, Hashimoto J, Ohkubo T, Tsuji I, Nagai K, Kikuya M, Hozawa A, Matsubara M, Suzuki M, Fujiwara T, Araki T, Satoh H, Hisamichi S, Imai Y. Insufficient duration of action of antihypertensive drugs mediates high blood pressure in the morning in hypertensive population: The Ohasama study. Clin Exp Hypertens. 2002;24:261-275.
8. Asayama K, Ohkubo T, Kikuya M, Obara T, Metoki H, Inoue R, Hara A, Hirose T, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y. Prediction of stroke by home "morning" versus "evening" blood pressure values; The Ohasama study. Hypertension. 2006;48:737-743.
9. Chobanian AV. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The JNC 7 Report. JAMA. 2003;289:2560-2572.
10. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.
11. Japanese Society of Hypertension. Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Hypertens Res. 2006;29:S1-105.
12. Toutain PL, Lefebvre HP. Pharmacokinetics and pharmacokinetic/ pharmacodynamic relationships for angiotensin-converting enzyme inhibitors. J Vet Pharmacol Ther. 2004;27:515-525.
13. Imai Y, Ohkubo T, Hozawa A, Tsuji I, Matsubara M, Araki T, Chonan K, Kikuya M, Satoh H, Hisamichi S, Nagai K. Usefulness of home blood pressure measurement in assessing the effect of treatment in a single-blind placebo-controlled open trial. J Hypertens. 2001;19:179-185.
14. Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens. 2004;22:1099-1104.
15. Chonan K, Kikuya M, Araki T, Fujiwara T, Suzuki M, Michimata M, Hashimoto J, Ohkubo T, Hozawa A, Yamamoto N, Miyawaki Y, Matsubara M, Imai Y. Device for the self-measurement of blood pressure that can monitor blood pressure during sleep. Blood Press Monit. 2001;6:203-205.
16. Imai Y, Ohkubo T, Kikuya M, Hashimoto J. Practical aspect of monitoring hypertension based on self-measured blood pressure at home. Intern Med. 2004;43:771-778.
17. Hozawa A, Ohkubo T, Nagai K, Kikuya M, Matsubara M, Tsuji I, Ito S, Satoh H, Hisamichi S, Imai Y. Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: The Ohasama study. Arch Intern Med. 2000;160:3301-3306.
18. Menard J, Chatellier G, Day M, Vaur L. Self-measurement of blood pressure at home to evaluate drug effects by the trough:peak ratio. J Hypertens. 1994;12:S21-S25.
19. Zannad F, Vaur L, Dutrey-Dupagne C, Genes N, Chatellier G, Elkik F, Menard J. Assessment of drug efficacy using home self-blood pressure measurement: The SMART study. J Hum Hypertens. 1996;10:341-347.
20. Fenichel RR, Lipicky RJ. On the trough-to-peak ratio of drug effect in antihypertensive trials. Am J Hypertens. 1996;9:105S-107S.
21. Imai Y, Ohkubo T, Hozawa A, Tsuji I, Matsubara M, Araki T, Chonan K, Kikuya M, Satoh H, Hisamichi S, Nagai K. Usefulness of home blood pressure measurement in assessing the effect of treatment in a single-blind placebo-controlled open trial. J Hypertens. 2001;19:179-185.
22. Woolson RF. Statistical methods for the analysis of biomedical data. Chichester: John Wiley & Sons; 1987.
23. Kuroda T, Kario K, Hoshide S, Hashimoto T, Nomura Y, Saito Y, Mito H, Shimada K. Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. Hypertens Res. 2004;27:15-20.
24. Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15:205-211.
25. Palatini P. Importance of various methods of blood pressure measurement in clinical trials. Curr Hypertens Rep. 2000;2:362-369
26. Meredith PA. Trough:peak ratio and smoothness index for antihypertensive agents. Blood Press Monit. 1999;4:257-262.
27. Vaur L, Dubroca I, Dutrey-Dupagne C, Genes N, Chatellier G, Bouvier-d'Yvoire M, Elkik F, Menard J. Superiority of home blood pressure measurements over office measurements for testing antihypertensive drugs. Blood Press Monit. 1998;3:107-114.
28. Sekino M, Imai Y, Ohkubo T, Omae T. Differential effects of antihypertensive drugs with differing pharmacological properties on the basal ambulatory blood pressure. Japanese Ambulatory Pressure-ANtihypertensive Effects SEarching (JAPANESE) study group. J Hum Hypertens. 1998;12:719-726.
29. Lemmer B. The chronopharmacology of cardiovascular medications. Ann Rev Chronopharmacol. 1986;2:199-228.
30. Brandenberger G, Follenius M, Goichot B, Saini J, Spiegel K, Ehrhart J, Simon C. Twenty-four-hour profiles of plasma renin activity in relation to the sleep-wake cycle. J Hypertens. 1994;12:277-283.
31. Banegas JR, Segura J, Ruilope LM, Luque M, Garcia-Robles R, Campo C, Rodriguez-Artalejo F, Tamargo J; CLUE Study Group Investigators. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain. Hypertension. 2004;43:1338-1344.
32. Obara T, Ohkubo T, Funahashi J, Kikuya M, Asayama K, Metoki H, Oikawa T, Hashimoto J, Totsune K, Imai Y. Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study. J Hypertens. 2005;23:1653-1660.
33. Hozawa A, Ohkubo T, Kikuya M, Ugajin T, Yamaguchi J, Asayama K, Metoki H, Ohmori K, Hoshi H, Hashimoto J, Satoh H, Tsuji I, Imai Y. Prognostic value of home heart rate for cardiovascular mortality in the general population: The Ohasama Study. Am J Hypertens. 2004;17:1005-1010.